C4 Therapeutics Inc - ESG Rating & Company Profile powered by AI
This SDG score for C4 Therapeutics Inc represents its transparency towards the UN Sustainable Development Goals. Comprehensive Sustainability assessment of C4 Therapeutics Inc are reached by signing up for free. The page contains a questions and answers table for C4 Therapeutics Inc.
C4 Therapeutics Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 1.7; made up of an environmental score of 2.0, social score of 0.0 and governance score of 3.2.
1.7
Low ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| ... | ... | ... | |
| 1631 | Viewbix Inc | 1.8 | Low |
| 1631 | dorsaVi Ltd | 1.8 | Low |
| 1682 | C4 Therapeutics Inc | 1.7 | Low |
| 1682 | Abcellera Biologics Inc | 1.7 | Low |
| 1682 | Alfresa Holdings Corp | 1.7 | Low |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does C4 Therapeutics Inc have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes C4 Therapeutics Inc disclose current and historical energy intensity?
Sign up for free to unlockDoes C4 Therapeutics Inc report the average age of the workforce?
Sign up for free to unlockDoes C4 Therapeutics Inc reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes C4 Therapeutics Inc disclose its ethnicity pay gap?
Sign up for free to unlockDoes C4 Therapeutics Inc disclose cybersecurity risks?
Sign up for free to unlockDoes C4 Therapeutics Inc offer flexible work?
Sign up for free to unlockDoes C4 Therapeutics Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes C4 Therapeutics Inc disclose the number of employees in R&D functions?
Sign up for free to unlockDoes C4 Therapeutics Inc conduct supply chain audits?
Sign up for free to unlockDoes C4 Therapeutics Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes C4 Therapeutics Inc conduct 360 degree staff reviews?
Sign up for free to unlockDoes C4 Therapeutics Inc disclose the individual responsible for D&I?
Sign up for free to unlockDoes C4 Therapeutics Inc disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes C4 Therapeutics Inc disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes C4 Therapeutics Inc disclose water use targets?
Sign up for free to unlockDoes C4 Therapeutics Inc have careers partnerships with academic institutions?
Sign up for free to unlockDid C4 Therapeutics Inc have a product recall in the last two years?
Sign up for free to unlockDoes C4 Therapeutics Inc disclose incidents of discrimination?
Sign up for free to unlockDoes C4 Therapeutics Inc allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas C4 Therapeutics Inc issued a profit warning in the past 24 months?
Sign up for free to unlockDoes C4 Therapeutics Inc disclose parental leave metrics?
Sign up for free to unlockDoes C4 Therapeutics Inc disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes C4 Therapeutics Inc disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes C4 Therapeutics Inc disclose the pay ratio of women to men?
Sign up for free to unlockDoes C4 Therapeutics Inc support suppliers with sustainability related research and development?
Sign up for free to unlockDoes C4 Therapeutics Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes C4 Therapeutics Inc reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs C4 Therapeutics Inc involved in embryonic stem cell research?
Sign up for free to unlockDoes C4 Therapeutics Inc disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes C4 Therapeutics Inc disclose its waste policy?
Sign up for free to unlockDoes C4 Therapeutics Inc report according to TCFD requirements?
Sign up for free to unlockDoes C4 Therapeutics Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes C4 Therapeutics Inc disclose energy use targets?
Sign up for free to unlockDoes C4 Therapeutics Inc disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes C4 Therapeutics Inc have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for C4 Therapeutics Inc
These potential risks are based on the size, segment and geographies of the company.
C4 Therapeutics, Inc., a biopharmaceutical company, develops novel therapeutic candidates to target and destroy disease-causing proteins for the treatment of cancer, neurodegenerative conditions, and other diseases. Its lead product candidate is CFT7455, an orally bioavailable degrader that is in preclinical stage targeting IKZF1/3 for multiple myeloma and non-Hodgkin lymphomas, including peripheral T-cell lymphoma and mantle cell lymphoma. The company is also developing CFT8634, an orally bioavailable degrader of BRD9, a protein target for synovial sarcoma and SMARCB1-deleted solid tumors; and BRAF V600E to treat melanoma, non-small cell lung cancer, colorectal cancer, and other solid malignancies, as well as RET to treat lung cancer, sporadic medullary thyroid cancers, and other solid malignancies. C4 Therapeutics, Inc. has strategic collaborations with F. Hoffman-La Roche Ltd.; Biogen, Inc.; and Calico Life Sciences LLC. The company was incorporated in 2015 and is headquartered in Watertown, Massachusetts.